These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient. Niessen HG, Angenstein F, Sander K, Kunz WS, Teuchert M, Ludolph AC, Heinze HJ, Scheich H, Vielhaber S. Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261 [Abstract] [Full Text] [Related]
3. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Sharp PS, Dick JR, Greensmith L. Neuroscience; 2005 Oct; 130(4):897-910. PubMed ID: 15652988 [Abstract] [Full Text] [Related]
5. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Jiang HQ, Ren M, Jiang HZ, Wang J, Zhang J, Yin X, Wang SY, Qi Y, Wang XD, Feng HL. Neuroscience; 2014 Sep 26; 277():132-8. PubMed ID: 24699224 [Abstract] [Full Text] [Related]
7. Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Niessen HG, Debska-Vielhaber G, Sander K, Angenstein F, Ludolph AC, Hilfert L, Willker W, Leibfritz D, Heinze HJ, Kunz WS, Vielhaber S. Eur J Neurosci; 2007 Mar 26; 25(6):1669-77. PubMed ID: 17432958 [Abstract] [Full Text] [Related]
8. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Kim J, Kim TY, Cho KS, Kim HN, Koh JY. Neurobiol Dis; 2013 Nov 26; 59():80-5. PubMed ID: 23891729 [Abstract] [Full Text] [Related]
9. Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice. Hossaini M, Cardona Cano S, van Dis V, Haasdijk ED, Hoogenraad CC, Holstege JC, Jaarsma D. J Neuropathol Exp Neurol; 2011 Aug 26; 70(8):662-77. PubMed ID: 21760539 [Abstract] [Full Text] [Related]
10. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Krishnan J, Vannuvel K, Andries M, Waelkens E, Robberecht W, Van Den Bosch L. J Neurochem; 2008 Sep 26; 106(5):2170-83. PubMed ID: 18624915 [Abstract] [Full Text] [Related]
11. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Jaarsma D, Haasdijk ED, Grashorn JA, Hawkins R, van Duijn W, Verspaget HW, London J, Holstege JC. Neurobiol Dis; 2000 Dec 26; 7(6 Pt B):623-43. PubMed ID: 11114261 [Abstract] [Full Text] [Related]
12. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis. Reinholz MM, Merkle CM, Poduslo JF. Exp Neurol; 1999 Sep 26; 159(1):204-16. PubMed ID: 10486188 [Abstract] [Full Text] [Related]
13. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice. Sheean RK, Weston RH, Perera ND, D'Amico A, Nutt SL, Turner BJ. J Neuroinflammation; 2015 Feb 27; 12():40. PubMed ID: 25889790 [Abstract] [Full Text] [Related]
14. Increased number and differentiation of neural precursor cells in the brainstem of superoxide dismutase 1(G93A) (G1H) transgenic mouse model of amyotrophic lateral sclerosis. Juan L, Dawei Z, Julie AD. Neurol Res; 2007 Mar 27; 29(2):204-9. PubMed ID: 17439705 [Abstract] [Full Text] [Related]
15. Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1(G93A) transgenic mice. Kobayakawa Y, Sakumi K, Kajitani K, Kadoya T, Horie H, Kira J, Nakabeppu Y. Neuropathol Appl Neurobiol; 2015 Feb 27; 41(2):227-44. PubMed ID: 24707896 [Abstract] [Full Text] [Related]
16. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1. Tokuda E, Okawa E, Watanabe S, Ono S. Hum Mol Genet; 2014 Mar 01; 23(5):1271-85. PubMed ID: 24163136 [Abstract] [Full Text] [Related]
17. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation. Peviani M, Salvaneschi E, Bontempi L, Petese A, Manzo A, Rossi D, Salmona M, Collina S, Bigini P, Curti D. Neurobiol Dis; 2014 Feb 01; 62():218-32. PubMed ID: 24141020 [Abstract] [Full Text] [Related]
18. Ascending neuropathology in the CNS of a mutant SOD1 mouse model of amyotrophic lateral sclerosis. Leichsenring A, Linnartz B, Zhu XR, Lübbert H, Stichel CC. Brain Res; 2006 Jun 22; 1096(1):180-95. PubMed ID: 16737688 [Abstract] [Full Text] [Related]
19. Hypoxia causes autophagic stress and derangement of metabolic adaptation in a cell model of amyotrophic lateral sclerosis. Cimini S, Rizzardini M, Biella G, Cantoni L. J Neurochem; 2014 May 22; 129(3):413-25. PubMed ID: 24359187 [Abstract] [Full Text] [Related]
20. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Milanese M, Giribaldi F, Melone M, Bonifacino T, Musante I, Carminati E, Rossi PI, Vergani L, Voci A, Conti F, Puliti A, Bonanno G. Neurobiol Dis; 2014 Apr 22; 64():48-59. PubMed ID: 24361555 [Abstract] [Full Text] [Related] Page: [Next] [New Search]